ArticleCancer management and research2020

Evaluation of PCR-Reverse Dot Blot Human Papillomavirus Genotyping Test in Predicting Residual/Recurrent CIN 2+ in Posttreatment Patients in China.

Qiaoyu Zhang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.